Lung inflammation as a therapeutic target in cystic fibrosis.
about
Inhaled corticosteroids for cystic fibrosisInhaled corticosteroids for cystic fibrosisInhaled corticosteroids for cystic fibrosisInflammasome-mediated IL-1β production in humans with cystic fibrosisEicosanoid release is increased by membrane destabilization and CFTR inhibition in Calu-3 cellsPseudomonas aeruginosa biofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies.Response of CFTR-deficient mice to long-term chronic Pseudomonas aeruginosa infection and PTX3 therapy.Bergamot (Citrus bergamia Risso) fruit extracts and identified components alter expression of interleukin 8 gene in cystic fibrosis bronchial epithelial cell lines.HE3286, an oral synthetic steroid, treats lung inflammation in mice without immune suppression.Stem cells and cell therapy approaches in lung biology and diseases.Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice.Stochastic tracking of infection in a CF lungA genomewide screen for chronic rhinosinusitis genes identifies a locus on chromosome 7q.Inflammatory markers of lung disease in adult patients with cystic fibrosis.Impaired cortical processing of inspiratory loads in children with chronic respiratory defects.Inflammation--a new therapeutic target in pneumonia.Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients.Glucocorticoid receptor gene polymorphisms associated with progression of lung disease in young patients with cystic fibrosisCystic fibrosis mouse models.New insights into pulmonary inflammation in cystic fibrosis.DNA and inflammatory mediators in bronchoalveolar lavage fluid from children with acute inhalational injuries.New use for an old drug: COX-independent anti-inflammatory effects of sulindac in models of cystic fibrosis.Potential role of high-mobility group box 1 in cystic fibrosis airway disease.Variants in mannose-binding lectin and tumour necrosis factor alpha affect survival in cystic fibrosis.Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography.Intensive care management of the patient with cystic fibrosis.Post-transcriptional regulation of cystic fibrosis transmembrane conductance regulator expression and function by microRNAs.The KCTD family of proteins: structure, function, disease relevance.Modulation of Treg function improves adenovirus vector-mediated gene expression in the airway.Fenofibrate Attenuates Neutrophilic Inflammation in Airway Epithelia: Potential Drug Repurposing for Cystic Fibrosis.Self-reactive CFTR T cells in humans: implications for gene therapy.Transcription factor oligodeoxynucleotides to NF-kappaB inhibit transcription of IL-8 in bronchial cells.Expression of microRNA-93 and Interleukin-8 during Pseudomonas aeruginosa-mediated induction of proinflammatory responses.Effects of decoy molecules targeting NF-kappaB transcription factors in Cystic fibrosis IB3-1 cells: recruitment of NF-kappaB to the IL-8 gene promoter and transcription of the IL-8 gene.Trimethylangelicin reduces IL-8 transcription and potentiates CFTR function.Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells.Ciprofloxacin during upper respiratory tract infections to reduce Pseudomonas aeruginosa infection in paediatric cystic fibrosis: a pilot study.Rescuing ΔF508 CFTR with trimethylangelicin, a dual-acting corrector and potentiator.FDG-PET imaging of pulmonary inflammation in healthy volunteers after airway instillation of endotoxin.Regulation of normal and cystic fibrosis airway epithelial repair processes by TNF-α after injury.
P2860
Q24193120-F4C5B799-9F65-4D91-9A32-E5250EFB1D2EQ24202923-58CADF5F-C68D-43CE-A73A-30E7EB757F21Q24241634-F6200C0D-4E2B-4662-8A31-9618CE32059DQ28483902-2619BD65-0555-4A83-8430-E99433352C66Q33511751-9B5BB95E-EA79-445B-9004-2F87AEFDF407Q33522442-E0B8567F-9309-4553-8B78-8F9CEB6F91B7Q33749315-FDAB0CA7-CC7E-43ED-8383-45E5F99DF579Q33874258-329BAA97-5DC4-4E46-B59E-1A8F751D0A0CQ34321838-E72A4660-828A-471D-AE41-5BDACBD48287Q34361245-FA2B488D-A95B-4E3D-9F3C-97ADD665395DQ34426614-C4E94905-F99A-44BA-B84F-C61DCFEC13B7Q34434661-794EB5C7-3B16-4B04-9FAB-7437AF951A84Q34886306-4991FDCC-F73E-432F-93C7-AAE3A7D294C0Q35749974-1D92D210-2C90-408B-9FE9-369768969540Q36062976-19F6E05A-7431-4CFC-8900-BFA13AC5B8AFQ36095647-CA67C5DD-B018-4913-AE3E-B4B96F3E002CQ36142593-F83F3B44-B871-46D6-9523-282DA1117287Q36412679-7FD20D2A-E868-4DFF-BFF8-84FCBACD14A1Q36556391-0F215E55-5FB0-4892-97F8-7BDD43933585Q36573117-15D0D341-E831-4D75-A5A7-F09316A0D8D7Q36594975-972EC229-7256-452F-8307-8D42CC9254F1Q36903409-3425EBC5-6439-40AD-818D-E5335CDEC6F7Q36935244-E1BC8D52-FDD7-42E9-BB21-F780E17F5039Q37004728-6C80C8BB-A896-48CF-AA06-8C0B23BBF1B0Q37144524-D12AD8B7-2B9C-4C86-81A8-E8E65EC5158AQ37149666-FEAEB405-98BD-4C5F-A336-40AD1892BA58Q37297935-0F085D39-9D18-49F3-8CE0-011E0FFF274EQ37438780-AD70BFED-C5B5-4AFB-B935-51A832762118Q37624300-5E6534AE-CB37-4598-9F9C-2677B441D632Q37700876-47C619D0-72D3-41CB-9196-B1D0980A7BD9Q37730119-9D9512D1-C625-4FCD-AF3C-9898A0E56848Q38293726-072425F0-66BB-47A0-A449-079E030655F6Q39033925-E7747F46-27A0-4942-96F6-4A191A1E3FBDQ39318131-20BAECEE-B597-4413-8A48-A143DA3A9E9CQ39621248-FFE617D3-A70D-467B-A13C-3C3D4906ADAEQ40185293-4F806F85-3531-4A66-A744-91D2A897FB9FQ41015058-967C7EC3-F681-4B5E-8640-18B8610D621AQ44455766-83E739BF-819B-4B69-8145-3772018B179BQ46902103-CBDFE1EA-8A90-49D2-B9AB-F351F30F8862Q54561607-37306395-2984-4C29-A5A4-6309FCB950BD
P2860
Lung inflammation as a therapeutic target in cystic fibrosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Lung inflammation as a therapeutic target in cystic fibrosis.
@ast
Lung inflammation as a therapeutic target in cystic fibrosis.
@en
type
label
Lung inflammation as a therapeutic target in cystic fibrosis.
@ast
Lung inflammation as a therapeutic target in cystic fibrosis.
@en
prefLabel
Lung inflammation as a therapeutic target in cystic fibrosis.
@ast
Lung inflammation as a therapeutic target in cystic fibrosis.
@en
P2093
P2860
P356
P1476
Lung inflammation as a therapeutic target in cystic fibrosis
@en
P2093
A Keith Tanswell
David R Koehler
Neil B Sweezey
P2860
P304
P356
10.1165/RCMB.2004-0124TR
P577
2004-10-01T00:00:00Z